NYSE:STEMedical Equipment
Steris (STE) Margin Improvement Reinforces Bullish Narratives Despite Premium P/E Multiple
STERIS (STE) has put fresh numbers on the table for FY 2026, with Q4 revenue of US$1.6 billion and basic EPS of US$2.25, framed against trailing 12 month revenue of US$5.9 billion and EPS of US$7.97, alongside earnings growth of 28.2% over the past year and a five year annualized earnings growth rate of 21.6%. Over recent periods, quarterly revenue has ranged from US$1.4 billion to US$1.6 billion while basic EPS has moved between US$1.80 and US$2.25, and investors now have a clearer view of...